Binding studies of truncated variants of the Aβ peptide to the V-domain of the RAGE receptor reveal Aβ residues responsible for binding

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1814, Issue 5, 2011, Pages 592-609

  Gospodarska, Emilia ^a   Kupniewska Kozak, Anna ^a   Goch, Grazyna ^a   Dadlez, Michal ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

Alzheimer's disease; Amyloid peptide; Fluorescence; Mass spectrometry; Receptor for advanced glycation endproducts

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; TRYPTOPHAN;

ARTICLE; CELL CULTURE; CELL INCLUSION; CELL TRANSPORT; CIRCULAR DICHROISM; CONTROLLED STUDY; KINETICS; LIGAND BINDING; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SPECTROFLUOROMETRY;

AMYLOID BETA-PEPTIDES; ANIMALS; BINDING SITES; CELL LINE; CIRCULAR DICHROISM; MASS SPECTROMETRY; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC;

MURINAE;

EID: 79955115531     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2011.02.011     Document Type: Article

References (85)

1. A. Alzheimer Über eine eigenartige Erkrankung der Hirnrinde Neurologisches Centralblatt 23 1907 1129 1136
2. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
3. R.D. Terry Neuropathological changes in Alzheimer disease Prog. Brain Res. 101 1994 383 390 (Pubitemid 24084762)
4. A.E. Roher, J.D. Lowenson, S. Clarke, A.S. Woods, R.J. Cotter, E. Gowing, and M.J. Ball Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease Proc. Natl Acad. Sci. USA 90 1993 10836 10840
5. G.G. Glenner, and C.W. Wong Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein Biochem. Biophys. Res. Commun. 122 1984 1131 1135 (Pubitemid 14027629)
6. J. Nunan, and D.H. Small Regulation of APP cleavage by alpha-, beta-and gammasecretases FEBS Lett. 483 2000 6 10
7. B.A. Yankner, L.K. Duffy, and D.A. Kirschner Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250 1990 279 282
8. C. Geula, C.K. Wu, D. Saroff, A. Lorenzo, M. Yuan, and B.A. Yankner Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity Nat. Med. 4 1998 827 831 (Pubitemid 28331025)
9. A.C. McKee, N.W. Kowall, J.S. Schumacher, and M.F. Beal The neurotoxicity of amyloid beta protein in aged primates Amyloid 5 1998 1 9 (Pubitemid 128691210)
10. C.J. Pike, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity Brain Res. 563 1991 311 314
11. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
12. D.J. Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 1999 A23 A31
13. R. Gerlai Alzheimer's disease: beta-amyloid hypothesis strengthened! Trends Neurosci. 24 2001 199 (Pubitemid 32204369)
14. D.H. Small, S.S. Mok, and J.C. Bornstein Alzheimer's disease and Abeta toxicity: from top to bottom Nat. Rev. Neurosci. 2 2001 595 598 (Pubitemid 33679833)
15. W.L. Klein, G.A. Krafft, and C.E. Finch Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24 2001 219 224 (Pubitemid 32204378)
16. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid β-protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539 (Pubitemid 34288854)
17. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, P.M. Vassilev, D.B. Teplow, and D.J. Selkoe Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884 (Pubitemid 30226709)
18. A.E. Roher, M.O. Chaney, Y.M. Kuo, S.D. Webster, W.B. Stine, L.J. Haverkamp, A.S. Woods, R.J. Cotter, J.M. Tuohy, G.A. Krafft, B.S. Bonnell, and M.R. Emmerling Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease J. Biol. Chem. 271 1996 20631 20635 (Pubitemid 26281842)
19. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide Nature Reviews. Mol. Cell. Biol. 8 2007 101 112 (Pubitemid 46432529)
20. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
21. M. Citron, T.S. Diehl, G. Gordon, A.L. Biere, P. Seubert, and D.J. Selkoe Evidence that the 42-and 40-amino acid forms of amyloid beta protein are generated from the beta amyloid precursor protein by different protease activities Proc. Natl Acad. Sci. USA 93 1996 13170 13175 (Pubitemid 26382788)
22. P. Seubert, C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schloss-macher, J. Whaley, and C. Swindlehurst Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids Nature 359 1992 325 327
23. M. Tabaton, M.G. Nunzi, R. Xue, M. Usiak, L. Autilio-Gambetti, and P. Gambetti Soluble amyloid beta protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid Biochem. Biophys. Res. Commun. 220 1994 1598 1603
24. C.L. Masters, G. Multhaup, G. Simms, J. Pottgiesser, R.N. Martins, and K. Beyreuther Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels EMBO J. 4 1985 2757 2763
25. R. Siman, J.P. Card, R.B. Nelson, and L.G. Davis Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage Neuron 3 1989 275 285
26. B.V. Zlokovic Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology Neurobiol. Dis. 4 1997 23 26
27. J.B. Mackic, M. Stins, J.G. McComb, M. Calero, J. Ghiso, K.S. Kim, S.D. Yan, D. Stern, A.M. Schmidt, B. Frangione, and B.V. Zlokovic Human blood-brain barrier receptors for Alzheimer amyloid-β1-40 assymetrical binding, endocytosis and transcytosis at the apical side of brain microvascular endothelial cell monolayer J. Clin. Invest. 102 1998 734 743 (Pubitemid 28399606)
28. R. Deane, S.D. Yan, R.K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A.M. Schmidt, D.L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, and B. Zlokovic RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain Nature Med. 9 2003 907 913 (Pubitemid 36889934)
29. M. Shibata, S. Yamada, S.R. Kumar, M. Calero, J. Bading, B. Frangione, D.M. Holtzman, C.A. Miller, D.K. Strickland, J. Ghiso, and B.V. Zlokovic Clearance of Alzheimer's amyloid β-peptide from brain by low density lipoprotein receptor related protein-1 in the blood brain barrier J. Clin. Invest. 106 2000 1489 1499 (Pubitemid 32038587)
30. J.S. Miners, S. Baig, J. Palmer, L.E. Palmer, P.G. Kehoe, and S. Love Abeta-degrading enzymes in Alzheimer's disease Brain Pathol. 18 2 2008 Apr. 240 252 Review
31. R. Deane, R.D. Bell, A. Sagare, and B.V. Zlokovic Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease CNS Neurol. Disord. Drug Targets 8 2009 16 30
32. F.M. LaFerla, K.N. Green, and S. Oddo Intracellular amyloid-beta in Alzheimer's disease Nat. Rev. Neurosci. 8 7 2007 Jul 499 509
33. K.A. Bates, G. Verdile, Q.S. Li, D. Ames, P. Hudson, C.L. Masters, and R.N. Martins Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests Mol. Psychiatry 14 2009 469 486
34. J.E. Donahue, S.L. Flaherty, C.E. Johanson, J.A. Duncan 3rd, G.D. Silverberg, M.C. Miller, R. Tavares, W. Yang, Q. Wu, E. Sabo, V. Hovanesian, and E.G. Stopa RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease Acta Neuropathol. 112 2006 405 415 (Pubitemid 44469161)
35. B.V. Zlokovic Clearing amyloid through the blood-brain barrier J. Neurochem. 89 4 2004 807 811 (Pubitemid 38684728)
36. A.M. Schmidt, M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao, C. Esposito, H. Hegarty, W. Hurley, and M. Clauss Isolation and characterisation of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface J. Biol. Chem. 267 1992 14987 14997
37. S.F. Yan, J. Lu, L. Xu, Y.S. Zou, J. Tongers, W. Kisiel, N. Mackman, D.J. Pinsky, and D.M. Stern Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis Nat. Med. 6 2000 643 651
38. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Invest. 108 2001 949 955 (Pubitemid 32946067)
39. O. Arancio, H.P. Zhang, X. Chen, C. Lin, F. Trinchese, D. Puzzo, S. Liu, A. Hegde, S.F. Yan, A. Stern, J.S. Luddy, L.F. Lue, D.G. Walker, A. Roher, M. Buttini, L. Mucke, W. Li, A.M. Schmidt, M. Kindy, P.A. Hyslop, D.M. Stern, and S.D. Yan RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice EMBO J. 23 2004 4096 4104
40. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A.M. Schmidt RAGE and Aβ peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691 (Pubitemid 26282167)
41. N. Origlia, M. Righi, S. Capsoni, A. Cattaneo, F. Fang, D.M. Stern, J.X. Chen, A.M. Schmidt, O. Arancio, S.D. Yan, and L. Domenici Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-b-mediated cortical synaptic dysfunction J. Neurosci. 28 2008 3521 3530 (Pubitemid 351469321)
42. S.D. Yan, A. Roher, M. Chaney, B. Zlokovic, A.M. Schmidt, and D. Stern Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptide Biochim. Biophys. Acta 1502 2000 145 157 (Pubitemid 30433864)
43. M. Neeper, A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, Y.C. Pan, K. Elliston, D. Stern, and A. Shaw Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins J. Biol. Chem. 267 1992 14998 15004
44. B.M. Dattilo, G. Fritz, E. Leclerc, C.W. Kooi, C.W. Heizmann, and W.J. Chazin The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units Biochemistry 46 2007 6957 6970 (Pubitemid 46906424)
45. S. Matsumoto, T. Yoshida, H. Murata, S. Harada, N. Fujita, S. Nakamura, Y. Yamamoto, T. Watanabe, H. Yonekura, H. Yamamoto, T. Ohkubo, and Y. Kobayashi Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE#RAGE interaction Biochemistry 47 2008 12299 12311
46. M.O. Chaney, W.B. Stine, T.A. Kokjohn, Y.M. Kuo, C. Esh, A. Rahman, D.C. Luehrs, A.M. Schmidt, D. Stern, S.D. Yan, and A.E. Roher RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling Biochim. Biophys. Acta 1741 2005 199 205 (Pubitemid 40825005)
47. W.G. Dougherty, S.M. Cary, and T.D. Parks Molecular genetic analysis of a plant virus polyprotein cleavage site: a model Virology 171 1989 356 364
48. A. Jabłonowska, M. Bakun, A. Kupniewska-Kozak, and M. Dadlez Alzheimer's disease Abeta peptide fragment 10-30 forms a spectrum of metastable oligomers with marked preference for N to N and C to C monomer termini proximity J. Mol. Biol. 344 2004 1037 1049 (Pubitemid 39491248)
49. H. Mach, C.R. Middaugh, and R.V. Lewis Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins Anal. Biochem. 200 1992 74 80
50. M.R. Eftink Fluorescence methods for studying equilibrium macromolecule-ligand interactions Methods Enzymol. 278 1997 221 258
51. M. Kloniecki, A. Jabłonowska, J. Poznanski, J. Langridge, C. Hughes, I. Campuzano, K. Giles, and M. Dadlez Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers J. Mol. Biol. 407 2011 110 124
52. www.macbiophotonics.ca/ImageJ.
53. T.E. Creighton Proteins. Structures and Molecular Properties 1996 W. H. Freeman and Company New York 163 167
54. Y. Goto, and K. Hamaguchi Formation of the intrachain disulphide bond in the constant fragment of the immunoglobulin light chain J. Mol. Biol. 146 1981 321 340 (Pubitemid 11106646)
55. C. Frech, and F.X. Schmidt Influence of protein conformation on disulfide bond formation in the oxidative folding of ribonuclease T1 J. Mol. Biol. 251 1995 135 149
56. J. Song, P. Bai, L. Luo, and Z. Peng Contribution of individual residues to formation of the native-like tertiary topology in the α-lactalbumin molten globule J. Mol. Biol. 280 1998 167 174 (Pubitemid 28312814)
57. M. Dadlez, and P.S. Kim Rapid formation of the native 14-38 disulfide bond in the early stages of BPTI folding Biochemistry 35 1996 16153 16164 (Pubitemid 27044077)
58. M. Dadlez Hydrophobic interactions accelerate early stages of the folding of BPTI Biochemistry 36 1997 2788 2797 (Pubitemid 27138560)
59. T. Ostendorp, E. Leclerc, A. Galichet, M. Koch, N. Demling, B. Weigle, C.W. Heizmann, P.M. Kroneck, and G. Fritz Structural and functional insights into RAGE activation by multimeric S100B EMBO J. 26 2007 3868 3878 (Pubitemid 47295872)
60. F.L. Yan, Y. Zheng, and F.D. Zhao Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia Acta Neuropathol. 116 2008 529 535
61. K.K. Kandimalla, O.G. Scott, S. Fulzele, M.W. Davidson, and J.F. Poduslo Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid β protein PLoS ONE 4 2009 4627 4647
62. A.M. Schmidt All on RAGE Curr. Mol. Med. 7 2007 697 698
63. E. Sturchler, A. Galichet, M. Weibel, E. Leclerc, and C.W. Heizmann Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity J. Neurosci. 28 2008 5149 5158
64. M.A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M.F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, and A.M. Schmidt RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901 (Pubitemid 29375048)
65. T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S.D. Yan, M. Hofmann, S.F. Yan, M. Pischetsrieder, D. Stern, and A.M. Schmidt N(epsilon)- (carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression J. Biol. Chem. 274 1999 31740 31749
66. E. Leclerc, G. Fritz, M. Weibel, C.W. Heizmann, and A. Galichet S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE immunoglobulin domains J. Biol. Chem. 282 2007 31317 31331 (Pubitemid 350044892)
67. S. Mruthinti, N. Capito, A. Sood, and J.J. Buccafusc Cytotoxicity of Abeta1-42, RAGE23-54 and an Abeta-RAGE complex in PC-12 cells Curr. Alzheimer Res. 4 2007 581 586 (Pubitemid 350248397)
68. P.T. Wilder, J. Lin, C.L. Bair, T.H. Charpentier, D. Yang, M. Liriano, K.M. Varney, A. Lee, A.B. Oppenheim, S. Adhya, F. Carrier, and D.J. Weber Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B Biochim. Biophys. Acta 1763 2006 1284 1297 (Pubitemid 44779856)
69. L.O. Tjernberg, D.J.E. Callaway, A. Tjernberg, S. Hahne, C. Lilliehöök, L. Terenius, J. Thyberg, and C. Nordstedt A molecular model of Alzheimer amyloid β-peptide fibril formation J. Biol. Chem. 274 1999 12619 12625
70. B.M. Austen, K.E. Paleologou, S.A. Ali, M.M. Qureshi, D. Allsop, and O.M. El-Agnaf Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide Biochemistry 47 2008 1984 1992 (Pubitemid 351287124)
71. A.J. Doig Peptide inhibitors of beta-amyloid aggregation Curr. Opin. Drug. Discov. Develop. 10 2007 533 539
72. D.M. Walsh, M. Townsend, M.B. Podlisny, G.M. Shankar, J.V. Fadeeva, O. El Agnaf, D.M. Hartley, and D.J. Selkoe Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation J. Neurosci. 25 2005 2455 2462 (Pubitemid 40365155)
73. R.K. Sundaram, C. Kasinathan, S. Stein, and P. Sundaram Detoxification depot for beta-amyloid peptides Curr. Alzheimer Res. 5 2008 26 32
74. M. Sadowski, J. Pankiewicz, H. Scholtzova, J.A. Ripellino, Y. Li, S.D. Schmidt, P.M. Mathews, J.D. Fryer, D.M. Holtzman, E.M. Sigurdson, and T. Wisniewski A synthetic peptide blocking the apolipoprotein E/β-amyloid binding mitigates β-amyloid toxicity and fibril formation in vitro and reduces β-amyloid plaques in transgenic mice Am. J. Pathol. 165 2004 937 948 (Pubitemid 39129300)
75. M. Sadowski, J. Pankiewicz, H. Scholtzova, P.D. Mehta, F. Prelli, D. Quartermain, and T. Wisniewski Blocking the apolipoprotein E/β-amyloid interaction as a potential therapeutic approach for Alzheimer's disease Proc. Natl Acad. Sci. USA 103 2006 18787 18792 (Pubitemid 44913488)
76. H.J. Huttunen, C. Fages, J. Kuja-Panula, A.J. Ridley, and H. Rauvala Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Cancer Res. 62 2002 4805 4811
77. J. Kallijarvi, M. Haltia, and M.H. Baumann Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta Biochemistry 40 2001 10032 10037 (Pubitemid 32800110)
78. D.M. Paresce, R.N. Ghosh, and F.R. Maxfield Microglial cells internalise aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor Neuron 17 1996 553 565 (Pubitemid 26322226)
79. H.Y. Wang, D.H.S. Lee, M.R. D' Andrea, P.A. Peterson, R.P. Shank, and A.B. Reitz Aβ(1-42) binds to α-7 nicotinic acetylcholine receptor with high affinity J. Biol. Chem. 275 2000 56265632
80. D. Giulian, L.J. Haverkamp, J. Yu, W. Karshin, D. Tom, J. Li, A. Kazanskaia, J. Kirkpatrick, and A.E. Roher The HHQK domain of β-amyloid provides a structural basis for the immunopathology of Alzheimer's disease J. Biol. Chem. 273 1998 29719 29726 (Pubitemid 28509983)
81. M. Yaar, S. Zhai, P.F. Pilch, S.M. Doyle, P.B. Eisenhauer, R.E. Fine, and B.A. Gilchrest Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis J. Clin. Invest. 100 1997 2333 2340
82. R.D. Bell, A.P. Sagare, A.E. Friedman, G.S. Bedi, D.M. Holtzman, R. Deane, and B.V. Zlokovic Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system J. Cereb. Blood Flow Metab. 27 2007 909 918 (Pubitemid 46659038)
83. P.N. Lacor, M.C. Buniel, L. Chang, S.J. Fernandez, Y. Gong, K.L. Viola, M.P. Lambert, P.T. Velasco, E.H. Bigio, C.E. Finch, G.A. Krafft, and W.L. Klein Synaptic targeting by Alzheimer's-related amyloid beta oligomers J. Neurosci. 24 2004 10191 10200 (Pubitemid 39492046)
84. Y. Gong, L. Chang, K.L. Viola, P.N. Lacor, M.P. Lambert, C.E. Finch, G.A. Krafft, and W.L. Klein Alzheimer's disease affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc. Natl Acad. Sci. USA 100 2003 10417 10422 (Pubitemid 37071893)
85. R. Deane, Z. Wu, and B.V. Zlokovic RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid-beta peptide clearance through transport across the blood-brain barrier Stroke 35 suppl. I 2004 2628 2631 (Pubitemid 39458354)